0 Comentários
0 Compartilhamentos
778 Visualizações
0 Anterior
Pesquisar
Conheça novas pessoas, crie conexões e faça novos amigos
- Faça Login para curtir, compartilhar e comentar!
- Heart Failure POC & LOC Devices Market Size, Shaping Future Trends and Growth from 2024-2031The global Heart Failure POC & LOC Devices Market , valued at USD 95.94 million in 2023, is projected to surge to USD 336.88 million by 2031. This growth represents a robust compound annual growth rate (CAGR) of 17% during the forecast period from 2024 to 2031. The increasing prevalence of heart failure, coupled with advancements in healthcare technology, is driving the adoption...0 Comentários 0 Compartilhamentos 506 Visualizações 0 Anterior
- “Market Dynamics in the UK Heart Failure Drugs Industry: Drivers, Challenges, and Innovations”UK Heart Failure Drugs Market: A Segmented View for Healthcare Professionals (2024) The UK heart failure drugs market presents a dynamic landscape for healthcare professionals. With an aging population and rising heart disease prevalence, the demand for effective heart failure medications is expected to soar. This report delves into the market segmentation, highlighting key players, recent...0 Comentários 0 Compartilhamentos 49 Visualizações 0 Anterior
- B Type Natriuretic Peptide as a Therapeutic Target in Heart Failure TreatmentDriven by the increasing incidence of cardiovascular diseases (CVDs) and a growing understanding of the importance of early diagnosis, global B-type natriuretic peptide (BNP) test market is on the rise. B-type natriuretic peptide (BNP) is a hormone released from the heart that is extremely important in diagnosing cardiac failure and other heart conditions. The projected demand for BNP testing...0 Comentários 0 Compartilhamentos 81 Visualizações 0 Anterior
- B Type Natriuretic Peptide: A Key Biomarker for Heart Failure DiagnosisDriven by the increasing incidence of cardiovascular diseases (CVDs) and a growing understanding of the importance of early diagnosis, global B-type natriuretic peptide (BNP) test market is on the rise. B-type natriuretic peptide (BNP) is a hormone released from the heart that is extremely important in diagnosing cardiac failure and other heart conditions. The projected demand for BNP testing...0 Comentários 0 Compartilhamentos 273 Visualizações 0 Anterior
- Bisoprolol Fumarate and Heart Failure with Preserved Ejection FractionHeart failure with preserved ejection fraction (HFpEF) is a type of heart failure in which the heart muscle is weakened, but the left ventricular ejection fraction (LVEF) is 50% or higher. The LVEF is a measure of how much blood the left ventricle pumps out with each contraction. Bisoprolol fumarate (Zebeta) is a beta-blocker that is used to treat a number of cardiovascular...0 Comentários 0 Compartilhamentos 1456 Visualizações 0 Anterior
- Cardiac Assist Devices — A Boon for Heart Failure PatientsCardiac assist devices, also known as heart pumps, are mechanical pumps that are used to partially or completely replace the function of a failing heart. They help improve the heart's ability to pump blood throughout the body and supply vital organs with oxygen-rich blood. There are various types of cardiac assist devices available today which can be implanted either temporarily or permanently...0 Comentários 0 Compartilhamentos 1306 Visualizações 0 Anterior
- Cardiac Assist Devices Are A Step Forward In Heart Failure ManagementCardiac Assist Devices have emerged as a significant advancement in the management of heart failure, revolutionizing the treatment options available for patients suffering from this debilitating condition. These devices provide mechanical support to the failing heart, helping it pump blood more efficiently and improving overall cardiac function. One of the most widely used cardiac assist device...0 Comentários 0 Compartilhamentos 1703 Visualizações 0 Anterior
- Combination Therapy & Gene Therapy: Unveiling the Future of Heart Failure TreatmentThe Evolving Landscape of the Heart Failure Drugs Market Heart failure, a chronic condition where the heart struggles to pump blood effectively, affects millions of people globally. Fortunately, the Heart Failure Drugs Market offers a variety of medications that can help manage symptoms, improve quality of life, and extend lifespan. This market is experiencing significant growth,...0 Comentários 0 Compartilhamentos 649 Visualizações 0 Anterior
- Congestive Heart Failure Drugs Market Report 2024 | Share & Forecast 2032IMARC Group's report titled "Congestive Heart Failure Drugs Market by Drug Class (ACE Inhibitors, Angiotensin 2 Receptor Blockers, Beta Blockers, Diuretics, Aldosterone Antagonists, Inotropes, and Others), Route of Administration (Oral, Intravenous), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), and Region 2024-2032". offers a comprehensive analysis of the...0 Comentários 0 Compartilhamentos 471 Visualizações 0 Anterior
- Cardiac Marker Testing Market Trends, Share Opportunities and Forecast By 2029A thorough discussion in the world class Cardiac Marker Testing report is sure to help client in studying the market on competitive landscape and has analysis of prime manufacturers, trends, opportunities, marketing strategies analysis, market effect factor analysis and consumer needs by major regions, types, and applications globally while considering the past, present and future state of the...0 Comentários 0 Compartilhamentos 7180 Visualizações 0 Anterior
- Congestive Heart Failure Drugs Market Size, Overview, Share and Forecast 2031The Congestive Heart Failure Drugs Market in 2023 is US$ 7.21 billion, and is expected to reach US$ 12.98 billion by 2031 at a CAGR of 7.60%. FutureWise Research published a report that analyzes Congestive Heart Failure Drugs Market trends to predict the market's growth. The report begins with a description of the business environment and explains the commercial summary of the chain structure....0 Comentários 0 Compartilhamentos 524 Visualizações 0 Anterior
- Congestive Heart Failure Market 2024 – Industry Analysis, Size, Share, Strategies and Forecast to 2032"According to the research report, the global congestive heart failure market was valued at USD 11.54 billion in 2021 and is expected to reach USD 18.48 billion by 2030, to grow at a CAGR of 5.4% during the forecast period." The quantitative market research report published by Polaris Market Research on Congestive Heart Failure Market 2024: By Types, Applications, Size,...0 Comentários 0 Compartilhamentos 448 Visualizações 0 Anterior
- Congestive Heart Failure Market Emerging Trends and Future Growth Analysis by 2032"According to the research report, the global congestive heart failure market was valued at USD 11.54 billion in 2021 and is expected to reach USD 18.48 billion by 2030, to grow at a CAGR of 5.4% during the forecast period." Polaris Market Research announces the release of its latest research report Congestive Heart Failure Market: By Size, Trends, Share, Growth, Segments,...0 Comentários 0 Compartilhamentos 223 Visualizações 0 Anterior
Páginas Impulsionadas